1. Home
  2. CTMX vs DTSQ Comparison

CTMX vs DTSQ Comparison

Compare CTMX & DTSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTMX
  • DTSQ
  • Stock Information
  • Founded
  • CTMX 2008
  • DTSQ 2022
  • Country
  • CTMX United States
  • DTSQ United States
  • Employees
  • CTMX N/A
  • DTSQ N/A
  • Industry
  • CTMX Biotechnology: Pharmaceutical Preparations
  • DTSQ
  • Sector
  • CTMX Health Care
  • DTSQ
  • Exchange
  • CTMX Nasdaq
  • DTSQ NYSE
  • Market Cap
  • CTMX 62.3M
  • DTSQ 89.8M
  • IPO Year
  • CTMX 2015
  • DTSQ 2024
  • Fundamental
  • Price
  • CTMX $0.80
  • DTSQ $10.15
  • Analyst Decision
  • CTMX Buy
  • DTSQ
  • Analyst Count
  • CTMX 6
  • DTSQ 0
  • Target Price
  • CTMX $5.77
  • DTSQ N/A
  • AVG Volume (30 Days)
  • CTMX 731.5K
  • DTSQ 36.9K
  • Earning Date
  • CTMX 03-10-2025
  • DTSQ 01-01-0001
  • Dividend Yield
  • CTMX N/A
  • DTSQ N/A
  • EPS Growth
  • CTMX N/A
  • DTSQ N/A
  • EPS
  • CTMX 0.16
  • DTSQ 0.17
  • Revenue
  • CTMX $126,617,000.00
  • DTSQ N/A
  • Revenue This Year
  • CTMX $22.55
  • DTSQ N/A
  • Revenue Next Year
  • CTMX N/A
  • DTSQ N/A
  • P/E Ratio
  • CTMX $4.93
  • DTSQ $61.02
  • Revenue Growth
  • CTMX 33.66
  • DTSQ N/A
  • 52 Week Low
  • CTMX $0.75
  • DTSQ $9.96
  • 52 Week High
  • CTMX $5.85
  • DTSQ $10.16
  • Technical
  • Relative Strength Index (RSI)
  • CTMX 41.61
  • DTSQ N/A
  • Support Level
  • CTMX $0.75
  • DTSQ N/A
  • Resistance Level
  • CTMX $0.98
  • DTSQ N/A
  • Average True Range (ATR)
  • CTMX 0.06
  • DTSQ 0.00
  • MACD
  • CTMX 0.00
  • DTSQ 0.00
  • Stochastic Oscillator
  • CTMX 20.13
  • DTSQ 0.00

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About DTSQ DT CLOUD STAR ACQUISITION CORP

DT Cloud Star Acquisition Corp is a blank check company.

Share on Social Networks: